Page last updated: 2024-11-05

tyramine and Metabolic Syndrome

tyramine has been researched along with Metabolic Syndrome in 2 studies

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patel, A1
Thompson, A1
Abdelmalek, L1
Adams-Huet, B1
Jialal, I1
Amaro, CA1
González-Cortazar, M1
Herrera-Ruiz, M1
Román-Ramos, R1
Aguilar-Santamaría, L1
Tortoriello, J1
Jiménez-Ferrer, E1

Other Studies

2 other studies available for tyramine and Metabolic Syndrome

ArticleYear
The relationship between tyramine levels and inflammation in metabolic syndrome.
    Hormone molecular biology and clinical investigation, 2019, Nov-06, Volume: 40, Issue:1

    Topics: Adult; Aged; Biomarkers; Female; Humans; Inflammation; Male; Metabolic Syndrome; Metabolomics; Middl

2019
Hypoglycemic and hypotensive activity of a root extract of Smilax aristolochiifolia, standardized on N-trans-feruloyl-tyramine.
    Molecules (Basel, Switzerland), 2014, Jul-31, Volume: 19, Issue:8

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Chromatography, High Pressure Liquid; Coumaric Aci

2014